• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者接受完全手术切除作为主要治疗后的监测:一项单中心回顾性队列研究

Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study.

作者信息

Fukumoto Chonji, Oshima Ryo, Sawatani Yuta, Shiraishi Ryo, Hyodo Toshiki, Kamimura Ryouta, Hasegawa Tomonori, Komiyama Yuske, Izumi Sayaka, Fujita Atsushi, Wakui Takahiro, Kawamata Hitoshi

机构信息

Department of Oral and Maxillofacial Surgery, Dokkyo Medical University School of Medicine, Mibu 321-0293, Tochigi, Japan.

Department of Oral and Maxillofacial Surgery, Kamma Memorial Hospital, Nasushiobara 325-0046, Tochigi, Japan.

出版信息

Cancers (Basel). 2021 Nov 21;13(22):5843. doi: 10.3390/cancers13225843.

DOI:10.3390/cancers13225843
PMID:34830994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8616227/
Abstract

BACKGROUND

The surveillance methods oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk for recurrence, and it is important to establish appropriate methods during the period in which latent/dormant cancer cells become more apparent. To investigate the appropriate surveillance of patients with OSCC based on the individual risk for recurrence and/or metastasis, we performed a retrospective cohort study after the complete surgical resection of OSCC as the primary treatment.

METHODS

The study was performed in 324 patients with OSCC who had been primarily treated with surgery from 2007 to 2020 at our hospital. We investigated the period, timing, and methods (visual examination, palpation and imaging using FDG-PET/CT or CECT) for surveillance in each case that comprised postsurgical treatment.

RESULTS

Regarding the time to occurrence of postsurgical events, we found that half of cases of local recurrence, cervical lymph node metastasis, and distant metastasis occurred within 200 days, and 75% of all of these events occurred within 400 days. However, the mean time for second primary cancer was 1589 days. The postsurgical events were detected earlier by imaging examinations than they were by visual examination and palpation.

CONCLUSIONS

For the surveillance of patients with OSCC after primary surgery, it is desirable to perform FDG-PET/CT within 3-6 months and at 1 year after surgery and to consider CECT as an option in between FDG-PET/CT, while continuing history and physical examinations for about 5 years based on individual risk assessment.

摘要

背景

口腔鳞状细胞癌(OSCC)患者的监测方法可根据复发风险来选择,在潜伏/休眠癌细胞变得更加明显的时期建立合适的方法很重要。为了基于个体复发和/或转移风险研究OSCC患者的适当监测方法,我们在OSCC作为主要治疗手段进行完全手术切除后开展了一项回顾性队列研究。

方法

该研究纳入了2007年至2020年在我院接受手术作为主要治疗的324例OSCC患者。我们调查了每例患者术后治疗中监测的时间、时机和方法(视觉检查、触诊以及使用FDG-PET/CT或CECT进行成像)。

结果

关于术后事件发生的时间,我们发现局部复发、颈部淋巴结转移和远处转移病例的一半在200天内发生,所有这些事件的75%在400天内发生。然而,第二原发性癌症的平均时间为1589天。成像检查比视觉检查和触诊更早发现术后事件。

结论

对于OSCC患者初次手术后的监测,理想的做法是在术后3至6个月以及1年时进行FDG-PET/CT检查,并在FDG-PET/CT检查之间考虑将CECT作为一种选择,同时根据个体风险评估持续进行约5年的病史和体格检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/4cdb00df8edc/cancers-13-05843-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/960e095bc2fd/cancers-13-05843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/a1722dfc72bd/cancers-13-05843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/a639fc57436e/cancers-13-05843-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/91c0396ef5bd/cancers-13-05843-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/ca69cdbc1c3a/cancers-13-05843-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/4cdb00df8edc/cancers-13-05843-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/960e095bc2fd/cancers-13-05843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/a1722dfc72bd/cancers-13-05843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/a639fc57436e/cancers-13-05843-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/91c0396ef5bd/cancers-13-05843-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/ca69cdbc1c3a/cancers-13-05843-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f4/8616227/4cdb00df8edc/cancers-13-05843-g006.jpg

相似文献

1
Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study.口腔鳞状细胞癌患者接受完全手术切除作为主要治疗后的监测:一项单中心回顾性队列研究
Cancers (Basel). 2021 Nov 21;13(22):5843. doi: 10.3390/cancers13225843.
2
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.氟代脱氧葡萄糖正电子发射断层显像/增强CT作为头颈部鳞状细胞癌的治疗后评估工具:与氟代脱氧葡萄糖正电子发射断层显像/非增强CT及增强CT的比较
Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.
3
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.18F 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在口腔鳞状细胞癌原发分期中的准确性。
JAMA Netw Open. 2021 Apr 1;4(4):e217083. doi: 10.1001/jamanetworkopen.2021.7083.
4
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node.(18)F-氟脱氧葡萄糖正电子发射断层扫描、计算机断层扫描和磁共振成像在病理检查颈部淋巴结阳性的口腔鳞状细胞癌中的预后价值
Radiat Oncol J. 2012 Dec;30(4):173-81. doi: 10.3857/roj.2012.30.4.173. Epub 2012 Dec 31.
5
Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.回顾性评估 NI-RADS 检测口腔鳞状细胞癌术后 CT 或 MRI 监测中的复发。
AJR Am J Roentgenol. 2021 Jul;217(1):198-206. doi: 10.2214/AJR.20.24209. Epub 2020 Sep 2.
6
Comorbidity Assessment in Patients With Oral Squamous Cell Carcinoma: Can Imaging Techniques (Fludeoxyglucose Positron-Emission Tomographic Computed Tomography and Contrast-Enhanced Computed tomography) Provide Additional Information?口腔鳞状细胞癌患者的共病评估:成像技术(氟脱氧葡萄糖正电子发射断层扫描计算机断层扫描和增强计算机断层扫描)能否提供额外信息?
J Oral Maxillofac Surg. 2018 Jan;76(1):190-198. doi: 10.1016/j.joms.2017.05.024. Epub 2017 May 31.
7
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.3个月的F-18氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(F-18 FDG PET/CT)监测在手术切除的口腔鳞状细胞癌中的应用价值
Ann Otol Rhinol Laryngol. 2018 Mar;127(3):185-191. doi: 10.1177/0003489417751474. Epub 2018 Jan 9.
8
Three-Dimensional Image Fusion of F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Contrast-Enhanced Computed Tomography for Computer-Assisted Planning of Maxillectomy of Recurrent Maxillary Squamous Cell Carcinoma and Defect Reconstruction.用于复发性上颌鳞状细胞癌上颌骨切除术及缺损重建计算机辅助规划的F-氟脱氧葡萄糖-正电子发射断层扫描/计算机断层扫描与对比增强计算机断层扫描的三维图像融合
J Oral Maxillofac Surg. 2017 Jun;75(6):1301.e1-1301.e15. doi: 10.1016/j.joms.2017.02.013. Epub 2017 Feb 24.
9
Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.辅助治疗前进行第二次 FDG PET 扫描对口腔癌高危患者中检测残留/复发肿瘤的影响,这些患者存在病理性包膜外扩散。
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):944-55. doi: 10.1007/s00259-012-2103-2. Epub 2012 Mar 21.
10
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?18F-FDG-PET/CT参数作为口腔鳞状细胞癌的影像生物标志物,PET的视觉分析和增强CT对比是否比数值更好?
Eur J Radiol. 2015 Jun;84(6):1171-6. doi: 10.1016/j.ejrad.2015.02.030. Epub 2015 Mar 14.

引用本文的文献

1
Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs.表观遗传治疗改变免疫相关基因特征以提高抗PD-L1药物的敏感性。
Cancers (Basel). 2025 Jul 23;17(15):2431. doi: 10.3390/cancers17152431.
2
Recurrence Detection by Hybrid [ F]FDG-PET in Advanced Head and Neck Squamous Cell Carcinoma.18F-FDG-PET 融合显像在晚期头颈部鳞状细胞癌复发检测中的应用
Head Neck. 2025 Mar;47(3):936-943. doi: 10.1002/hed.27997. Epub 2024 Nov 8.
3
Difference between Keratinized- and Non-Keratinized-Originating Epithelium in the Process of Immune Escape of Oral Squamous Cell Carcinoma.

本文引用的文献

1
Effectiveness of cetuximab as preemptive postsurgical therapy for oral squamous cell carcinoma patients with major risk: a single-center retrospective cohort study.西妥昔单抗作为口腔鳞状细胞癌高危患者预防性术后治疗的有效性:一项单中心回顾性队列研究。
Invest New Drugs. 2021 Jun;39(3):846-852. doi: 10.1007/s10637-021-01062-0. Epub 2021 Jan 15.
2
Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro.紫杉醇通过增强抗体依赖性细胞细胞毒性增强西妥昔单抗对体外口腔鳞状细胞癌细胞的抗癌作用。
Int J Mol Sci. 2020 Aug 31;21(17):6292. doi: 10.3390/ijms21176292.
3
角化型和非角化型来源的口腔鳞状细胞癌在免疫逃避过程中的差异。
Int J Mol Sci. 2024 Mar 29;25(7):3821. doi: 10.3390/ijms25073821.
4
Post-treatment surveillance imaging in head and neck cancer: a systematic review.头颈部癌的治疗后监测成像:一项系统综述
Insights Imaging. 2024 Feb 5;15(1):32. doi: 10.1186/s13244-023-01578-4.
5
Oral Complications from Oropharyngeal Cancer Therapy.口咽癌治疗引起的口腔并发症。
Cancers (Basel). 2023 Sep 14;15(18):4548. doi: 10.3390/cancers15184548.
6
Temporal and spatial patterns of recurrence in oral squamous cell carcinoma, a single-center retrospective cohort study in China.中国单中心回顾性队列研究:口腔鳞状细胞癌的复发时空模式。
BMC Oral Health. 2023 Sep 19;23(1):679. doi: 10.1186/s12903-023-03204-7.
7
An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.在临床无症状的头颈部鳞状细胞癌患者中,采用基于 18F-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描的强化随访策略。
JAMA Netw Open. 2023 Aug 1;6(8):e2326654. doi: 10.1001/jamanetworkopen.2023.26654.
8
Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications.口腔鳞状细胞癌中癌干细胞起源的多样性及其临床意义
Cancers (Basel). 2022 Jul 22;14(15):3588. doi: 10.3390/cancers14153588.
9
Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR-144-3p and upregulating LPCAT1 in oral squamous cell carcinoma.环状LPAR3的下调通过释放miR-144-3p和上调LPCAT1来抑制口腔鳞状细胞癌的肿瘤进展和糖酵解。
Laryngoscope Investig Otolaryngol. 2022 Mar 11;7(2):425-436. doi: 10.1002/lio2.771. eCollection 2022 Apr.
Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.
cT1N0 颊黏膜鳞癌选择性颈清扫术与观望政策的比较。
BMC Cancer. 2020 Jun 9;20(1):537. doi: 10.1186/s12885-020-07006-w.
4
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.帕博利珠单抗单药或联合化疗对比西妥昔单抗联合化疗用于治疗复发性或转移性头颈部鳞状细胞癌(KEYNOTE-048):一项随机、开放标签、III 期研究。
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.
5
Elective neck dissection in oral squamous cell carcinoma: Past, present and future.口腔鳞状细胞癌选择性颈清扫术:过去、现在和未来。
Oral Oncol. 2019 Mar;90:87-93. doi: 10.1016/j.oraloncology.2019.01.016. Epub 2019 Feb 10.
6
Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution.口腔癌的临床特征及生存趋势:来自单一机构的3362例连续病例的五十年经验
Cancer Manag Res. 2018 Oct 12;10:4523-4535. doi: 10.2147/CMAR.S171251. eCollection 2018.
7
When should surveillance imaging be performed after treatment for head and neck cancer?头颈部癌症治疗后应何时进行监测成像?
Laryngoscope. 2017 Mar;127(3):533-534. doi: 10.1002/lary.26268. Epub 2017 Feb 10.
8
Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.头颈部癌颈部转移灶的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S161-S169. doi: 10.1017/S002221511600058X.
9
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
10
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.择期性与治疗性颈清扫术在淋巴结阴性口腔癌中的应用。
N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31.